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 ABSTRACT  
Background/Objective: Egg consumption has been associated with the risk of 
cardiovascular diseases (CVD), but evidence is scarce and inconsistent. Our 
aim was to examine the association between egg consumption and incidence of 
CVD in a prospective dynamic Mediterranean cohort of 14 185 university 
graduates. 
Subjects/Methods: Egg intake was assessed using a 136-item validated food 
frequency questionnaire. The baseline consumption was categorized into no 
consumption or <1/week, 1/week, 2-4/week, and >4/week. The presence of 
cardiovascular risk factors was assessed by questionnaire at baseline and the 
incidence of CVD was assessed using biennial assessments. The median 
follow-up was 6.1 years. Cox regression models were fitted to estimate 
multivariable-adjusted hazard ratios (HR) for CVD (myocardial infarction, 
revascularization procedures or stroke). Outcomes were confirmed by review of 
medical records. 
Results: During a median follow-up of 6.1 years, 91 new confirmed cases of 
CVD were observed. No association was found between egg consumption and 
the incidence of CVD (HR=1.10, 95% CI: 0.46-2.63) for the highest vs. the 
lowest category of egg consumption) after adjusting for age, sex, total energy 
intake, adherence to the Mediterranean food pattern and other cardiovascular 
risk factors. Results were robust to different analytical scenarios  
Conclusions: No association between egg consumption and the incidence of 
CVD was found in this Mediterranean cohort. 
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INTRODUCTION 
Cardiovascular diseases (CVD) remain a major public health problem and 
represent the leading cause of mortality and disability-adjusted life-years lost 
worldwide. In fact, mortality forecasts predict that deaths due to cancer and 
CVD will represent more than 50 % of total mortality in 2030 (WHO, 2008).   
The development of CVD is influenced by non-modifiable risk factors, such as 
older age, male sex, and by modifiable factors such as smoking, physical 
inactivity, alcohol and dietary factors (Barraj et al, 2009). Among them, the 
consumption of cholesterol rich-foods has been frequently invoked as a major 
risk factor for CVD (Qureshi et al, 2007).  
Guidelines from the American Heart Association recommend healthy adults to 
limit their dietary cholesterol intake to less than 300 mg/day on average (Krauss 
et al, 2000), and individuals with high LDL cholesterol, diabetes and/or CVD to 
reduce their dietary intake of cholesterol, including eggs, to <200 mg/day. The 
National Cholesterol Education Program recommends also reducing egg yolk 
consumption to <2/week as a way to reduce LDL cholesterol in individuals at 
increased risk of coronary heart disease (NCEP, 1994). 
Egg consumption has decreased in Spain from 300 units/person/year in 1987 to 
191 in 2007, probably as a result of public health recommendations to restrict 
egg intake (Cerdeño, 2008).  
Egg is a major source of dietary cholesterol with a typical egg containing on 
average 200 mg of cholesterol (Djousse & Gaziano, 2008). However, it is also a 
complete food and an inexpensive and low-calorie source of high quality protein 
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and other important nutrients such as minerals, folate and B vitamins, which 
could reduce the risk of CVD (Qureshi et al, 2007).  
On the other hand, current data on the effects of dietary cholesterol on serum 
cholesterol are limited and inconsistent, ranging from positive association to no 
effects (Djousse & Gaziano, 2008). Furthermore, there have been few 
epidemiological studies in free-living populations assessing the relationship 
between egg consumption and risk of CVD (Dawber et al, 1982; Fraser, 1994; 
Hu et al, 1999) and all of them were conducted in non-Mediterranean 
populations.  
The aim of our study was to prospectively examine the association between egg 
consumption and the risk of CVD in a prospective Mediterranean cohort, the 
SUN (Seguimiento Universidad de Navarra) study. 
 
SUBJECTS AND METHODS 
Study population 
The SUN Project is a multipurpose, dynamic cohort designed to study the 
prospective association of diet and other factors with various health outcomes, 
like hypertension, obesity, diabetes, and CVD (Martinez-Gonzalez et al, 2002).  
Briefly, the recruitment of participants, 97% come from Spain, started in 
December 1999 and it is permanently open. All participants are university 
graduates, with a high educational level, and more than fifty percent of them are 
health professionals themselves. Information is collected using self-
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administered questionnaires sent by postal mail every 2 years. The study 
methods have been published in detail elsewhere (Segui-Gomez et al, 2006).  
For this analysis, we included participants who had already been followed up for 
at least 2 years. All participants who answered the baseline questionnaire 
before September 2007 were eligible for this analyses (n=18 249) because they 
have been in the cohort for sufficient time as to be able to be assessed at least 
after 2-year follow-up. Among them, 2 173 had not answered any of the follow-
up questionnaires, and after five more mailings separated by 2 months each, 
they were considered lost to follow-up. We therefore retained 16 076 
participants (89.3%).  
We excluded those participants who self-reported baseline prevalent CVD 
(n=159), subjects who were outside predefined limits for total energy intake 
(<800 or > 4 000 kcal/d for men and <500 or > 3 500 kcal/d for women) (n=1 
500), and participants with missing values for egg consumption (n=232). After 
exclusions, 14 185 participants remained available for the analyses. 
The Institutional Review Board of the University of Navarra approved the study 
protocol. Voluntary completion of the baseline questionnaire was considered as 
informed consent. 
Assessment of egg consumption 
Egg consumption was assessed using a baseline semi-quantitative food-
frequency questionnaire (FFQ) (136 items), repeatedly validated in Spain 
(Martin-Moreno et al, 1993; Fernández- Ballart et al, 2010; De la Fuente et al, 
2010). Participants were asked to report how often they had consumed eggs of 
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hen (unit of consumption was 1 egg) during the previous year. This 
questionnaire had nine responses for each food item, that ranged from “never 
or almost never” to “≥6 times/day”.  
We divided the participants into 4 categories based on egg consumption: no 
consumption or <1/week, 1/week, 2-4/week, and >4/week. Trained dietitians 
derived energy and nutrient intake from Spanish food composition tables, using 
a computer program (Mataix, 2003; Moreiras, 2009).  Finally, food and nutrient 
intakes were adjusted for total energy intake using the residuals method (Willett 
et al, 1998). 
Assessment of other variables 
The baseline questionnaire collected also data on socio-demographic, 
anthropometric characteristics, lifestyle and health-related habits, family history, 
obstetric history for women and medical history.  
Information regarding physical activity during leisure-time was gathered at 
baseline with a specific questionnaire previously validated in Spain (Martinez-
Gonzalez et al, 2005), which assessed the time spent in 17 different activities. 
Each of these activities was assigned a multiple of the resting metabolic rate 
(MET score) (Ainsworth et al, 2000). Thus, taking also into account the weekly 
time spent in each activity, we obtained a value of overall weekly MET- hours 
for each participant.  
The validity of self-reported weight, BMI leisure-time physical activity and 
hypertension in the SUN cohort has been previously reported (Bes-Rastrollo et 
al, 2005; Martinez-Gonzalez  et al, 2005; Alonso et al, 2005).  
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Assessment of the outcome 
The baseline and follow-up questionnaires asked the participants if they had 
received a medical diagnosis of CVD, as well as the date of diagnosis. 
Participants were considered to have CVD at baseline if they reported a medical 
diagnosis of at least one of the following conditions: myocardial infarction, 
stroke, coronary artery bypass or coronary revascularization procedures. 
Incident cases of CVD were defined as those participants who did not have 
CVD at baseline and reported a physician’s diagnosis of CVD in the follow-up 
questionnaire. An expert panel of physicians, blinded to the information on diet 
and risk factors, adjudicated the events by reviewing medical records applying 
the universal criteria for myocardial infarction (Thygesen et al, 2007) or 
established clinical criteria for the other outcomes.  
The end-point for the present analysis was a composite outcome of incident 
CVD including either fatal or non-fatal myocardial infarction with or without ST 
elevation, coronary revascularization procedures, or fatal or non-fatal stroke.  
Statistical analysis 
Chi-square tests or ANOVA were used to compare proportions or means, 
respectively. We estimated hazard ratios (HR) and their 95% confidence 
intervals (CI) for the risk of incident CVD according to egg consumption at 
baseline using a multivariable Cox regression analysis. 
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Time of follow-up was defined as the time elapsed from the completion of the 
baseline questionnaire to the diagnosis to CVD or the date of the last follow-up 
questionnaire, whichever came earlier. 
We fitted three multivariable-adjusted models controlling for: a) age 
(continuous), sex, and baseline total energy intake (continuous), b) additionally 
adjusting for adherence to the Mediterranean food pattern (tertiles) 
(Trichopoulou et al, 1995; Martínez-González et al, 2009) and c) additionally 
adjusting for alcohol intake (4 categories), baseline BMI (Kg/m2, continuous), 
smoking status (never smoker, ex-smoker and current smoker), physical activity 
during leisure-time (MET-hours/week, continuous), family history of CVD years 
(yes/no), self-reported diabetes (yes/no), self-reported hypertension (yes/no), 
and self-reported hypercholesterolemia (yes/no).  
We considered the lowest category of egg consumption as the reference 
category.  
A number of sensitivity analyses were performed:  a) categorizing egg 
consumption into 5 categories instead of four, b) assigning the value 0 of egg 
consumption to missing values in this variable, c) excluding those participants 
who had prevalent diabetes or cancer at baseline; d) excluding subjects who 
were following a special diet at baseline; e) including in the outcome the cases 
of incident angina without revascularization and f) stratified analysis by age. 
Analyses were performed with SPSS version 15.0 (SPSS Inc., Chicago, Illinois, 
USA). All P values are two-tailed and statistical significance was set at the 
conventional cut-off of P <0.05. 
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RESULTS 
The mean age of participants at baseline was 38.4 years (range: 20 to 90 
years) and the median egg consumption was 3/week. The median follow-up 
was 6.1 years (mean=5.8 years).  
We observed 91 confirmed cases of CVD (probable cases were excluded) 
during the follow-up period: 34 myocardial infarctions, 29 revascularization 
procedures and 28 strokes.  
Table 1 presents the characteristics of the study population according to 
categories of egg consumption. Participants reporting higher consumption of 
eggs were more likely to be men, current smokers and physically more active 
and less likely to have history of hypertension, diabetes or 
hypercholesterolemia. On the other hand, participants reporting lower 
consumption of eggs were older and more likely to be ex-smokers.  
Egg consumption was positively related to total energy intake, total fat intake, 
polyunsaturated, saturated and monounsaturated fat intake. Egg consumption 
was also directly associated with the intake of cholesterol and alcohol, but 
inversely associated with carbohydrate and fibre intake.  
Table 2 shows the association between egg consumption and the incidence of 
CVD. The age-, sex- and total energy intake-adjusted HR of CVD comparing >4 
eggs/week with <1 egg/week was 1.10 (95% CI, 0.45-2.52). Additional 
adjustments for adherence to a Mediterranean food pattern or for several 
cardiovascular risk factors had no impact on the HRs: 1.08 (95% CI, 0.45-2.59) 
and 1.10 (95% CI, 0.46-2.63) respectively. 
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In an analysis dividing the highest intake category (>4 eggs/week) into two 
additional categories (5-6/week and ≥1/day), the adjusted HR for the highest 
category was 0.42 (95 % CI, 0.10-1.93), when compared to the lowest category.  
Results did not change when excluding participants with diabetes or cancer at 
baseline, or when we excluded subjects following a special diet at baseline or 
when we assigned a value of 0 for egg consumption to participants with missing 
values in egg consumption (data not shown). 
When we included in the definition of cardiovascular outcome the presence of 
angina not requiring revascularization, egg consumption (>4/week) was not 
associated with a higher cardiovascular risk: adjusted HR for the highest 
category: 0.96 (95 % CI: 0.46-2.00).  
Finally, stratified analysis by median age (36 years) was not possible due to 
insufficient number of CVD events in the younger group. For this reason we 
performed an additional analysis using as cut-off point 56 years of age, which 
left a similar number of events in both groups (47 events among the younger 
participants and 44 events among the older participants). The HR for CVD for 
the highest egg consumption category compared to the lowest egg consumption 
category among participants with <=56 and >56 years were respectively HR: 
0.47 (95% CI, 0.11-2.05) and 2.94 (95% CI, 0.93-9.30). The P value for 
interaction (likelihood ratio test) was 0.075. 
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DISCUSSION 
To our knowledge, this is the first large prospective cohort that has investigated 
the association between egg consumption and CVD risk in a free-living 
Mediterranean population. We found that egg consumption was not associated 
with a higher risk of CVD over 6 years of follow-up among Spanish graduates, 
but was positively associated with smoking, and a generally unhealthier eating 
pattern. 
Epidemiologic evidence relating directly egg consumption to coronary outcomes 
is relatively scarce and the dietary instruments used and the degree of control 
for confounding might improve (Kritchevsky, 2004). The only study that has 
specifically examined the relationship between egg consumption and CHD 
included 37 851 men and 80 082 women free of chronic diseases of the Health 
Professionals Follow-up Study and the Nurses Health Study (Hu et al., 1999). 
After adjusting for multiple confounders, those eating >7 eggs/week (as 
compared with those consuming <1 egg/week), had no increased risk of 
coronary heart disease (CHD) or stroke in either healthy men or women 
[RRmen= 1.08 (95 % CI, 0.79-1.48, RRwomen=0.82 (95 %CI, 0.60-1.13). 
In two other cohorts, eating eggs more frequently was not associated with an 
increase in CHD incidence (Nakamura et al, 2006) or in the risk of stroke or 
ischemic stroke (Qureshi et al, 2007). However, in these later studies, there was 
suggestive evidence for a detrimental association of higher egg consumption 
and increased cardiovascular risk only among diabetic subjects, among those 
with higher baseline blood cholesterol levels or only among older diabetics 
(Houston et al, 2010). 
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Furthermore, other findings had also been were very similar to our results 
(Dawber et al, 1982; Gramenzi et al, 1990; Djousse & Gaziano, 2008; Fraser, 
1994; Hu et al, 1999).  
Between 1 969 and 1 972, 5 133 Finnish men and women were assessed 
during a follow-up period of 16 years. After adjusting for age, there were no 
baseline differences in egg intake between those who died from CHD and those 
surviving to the end of the study (Knekt et al, 1994).  
Finally, in the California Adventist study there was no increase in coronary risk 
among those with higher egg consumption compared to those consuming < 
1/week (RR=1.01), but no adjustment for other dietary factors was reported 
(Fraser, 1999).  
On the contrary, to the best of our knowledge, only three studies have reported 
a detrimental effect of egg consumption on incident CHD (Mann et al, 1997; 
Burke et al, 2007; Nettleton et al, 2008). However, the results of the Oxford 
Vegetarian Study (Mann et al, 1997) need to be interpreted with caution 
because a number of potentially important confounding factors were not 
considered. On the other hand, the participants in the Australian Aboriginal 
study (Burke et al, 2007), were clearly very different to those in our cohort. 
Different mechanisms might explain the lack of relationship between egg 
consumption and incident CVD. First, in spite that hypercholesterolemia is a 
classic risk factor for CVD and that egg contributes approximately 30 % of the 
dietary cholesterol, a decrease in plasmatic total cholesterol levels after a 
reduction in dietary cholesterol of 100 mg/d is observed only in 30% of subjects. 
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Probably, dietary cholesterol intake is regulated by a vast number of genes 
(Herron & Fernandez, 2004, McNamara, 2000). However, there is evidence that 
some populations may benefit from low cholesterol intake, such as diabetics 
who may possess an abnormality in the mechanism by which they transport 
cholesterol (Hu et al, 1999; Qureshi  et al, 2007).  
Second, some dietary patterns (e.g. the Mediterranean pattern) may lead to 
lower CVD risk than those based only in reducing saturated fat and cholesterol 
intake (Kritchevsky, 2004; Martinez-Gonzalez et al, 2010; Buckland et al, 2009; 
Sofi et al, 2008). For example, in Japan the rates of coronary disease have 
continued to fall, although their food pattern includes eating egg frequently. 
However, the Japanese diet is relatively low in total fat and saturated fat.  
Third, the relationship of egg consumption with cardiovascular outcomes 
depends not only on the dietary cholesterol from eggs themselves, but also on 
the total cholesterol intake provided by the overall food pattern (Kritchevsky & 
Kritchevsky, 2000). In our study, thanks to the semi-quantitative FFQ, an index 
of adherence to an overall food pattern and intake of energy and specific 
nutrients were available; therefore, we adjusted for potential dietary 
confounders, including the overall food pattern, and despite this, we found not 
association between egg consumption and incidence of CVD.   
Fourth, despite egg consumption has been associated with the prevention and 
treatment of specific symptoms associated with chronic age-related diseases  
(Herron & Fernandez, 2004) and with an increased risk of type 2 diabetes in 
men and women (Djoussé et al, 2009), it has not shown to adversely affect 
other cardiovascular risk factors (i.e. blood pressure) (Qureshi et al, 2007). 
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Fifth, egg contained many other nutrients besides cholesterol, including 
unsaturated fats which may be beneficial in preventing CVD. Finally, eggs are 
less rich in saturated fat than many other protein foods, so they may have only 
a minor effect on cholesterol levels (Kritchevsky & Kritchevsky, 2000). 
Our study has several methodological limitations. Our cohort is a non-
representative sample of the general Spanish population since it is a young 
cohort formed entirely by university graduates. However, there is no biological 
reason to think that our results cannot be generalized to other population 
groups but social and/or educational background should not be ignored, and we 
consider that a strong internal validity is the first step to support the external 
validity of our findings. Besides, residual confounding might have not been 
totally excluded. However, we performed the analyses adjusting for the main 
known risk factors, and we do not consider residual confounding as a likely 
important cause to explain the observed results.  
Another limitation is that the statistical power of our study might have been 
limited to detect associations between egg consumption and CVD. This 
limitation is especially important when considering subtypes of CVD, specific 
risk of CVD among diabetic participants or the potential interaction between age 
and egg consumption. The P value (0.075) that we found for age x egg 
consumption deserves confirmation in future studies. 
Finally, we are probably underestimating egg consumption since we only used 
the units consumed, without considering eggs that might be ingredients in other 
foods (e.g. pastries).  
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The strengths of this study are that we are using data of a well-known 
Mediterranean cohort (the SUN study) with a relatively large sample size, a high 
response rate, a sufficiently long period of follow-up. The prospective design of 
our study could avoid the possible effect of reverse causality in the reported 
associations. In addition, we were able to control for a wide variety of potential 
confounders. Besides, the robustness of our findings in sensitivity analyses is 
other strength.  
In conclusion, our data suggest that a higher egg consumption was not 
associated with any apparent increase in CVD risk among initially healthy 
middle-aged adults. Further research on the biological mechanisms behind the 
potentially increased CVD risk with frequent egg consumption is warranted. 
Perhaps, efforts to promote healthy lifestyles related to smoking, exercise, 
weight reduction and other dietary aspects are likely to have a greater impact 
on CHD, than those related to reduce egg consumption. Finally, further 
confirmation of our findings is needed through cohort studies with more 
statistical power and repeated measurement of diet and/or clinical trials. 
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Table 1. Main characteristics of the 14 185 participants of the SUN cohort according to baseline on 
egg consumption (Mean and standard deviations or percentages)  










Age (years) 41.6 38.7 38.0 38.1 < 0.001 
Baseline BMI (kg/m 2) 23.9 23.5 23.5 24.0 < 0.001 
Baseline weight (kg) 67.8 66.3 67.0 70.0 < 0.001 
Physical activity during leisure time (METs-
h/week) 
23.2 23.8 23.9 26.6 < 0.001 
Men (%) 42.4 36.5 39.5 55.6 < 0.001 
Smoking status     0.006 
Ex-smoker (%) 34.1 30.6 29.0 28.1  
Current smoker (%) 22.8 22.4 21.9 23.5  
Hypertension at baseline (%) 14.1 11.1 9.8 10.7 < 0.001 
Diabetes at baseline (%) 2.6 1.7 1.8 1.5 0.191 
Hypercholesterolemia at baseline (%) 29.1 22.3 18.6 15.3 < 0.001 
Following a special diet at baseline (%) 14.4 9.1 7.4 5.8 < 0.001 
Mediterranean Diet Score (Trichopoulou et al) 4.5 4.4 4.3 4.0 < 0.001 
Total energy intake (kcal/day) 2058 2199 2406 2642 < 0.001 
Carbohydrate intake (% total energy) 45.4 44.1 43.0 42.0 < 0.001 
Protein intake (% total energy) 18.2 18.3 18.1 18.0 0.048 
Fat intake (% total energy) 34.0 35.6 36.9 37.9 < 0.001 
Polyunsaturated fatty acid intake (% total energy) 4.9 5.0 5.3 5.4 < 0.001 
Saturated fatty acid intake (% total energy) 11.2 12.1 12.6 13.2 < 0.001 
Monounsaturated fatty acid intake (% total energy) 14.7 15.3 15.8 16.1 < 0.001 
Cholesterol intake (mg/day) 280.8 338.9 434.5 584.0 < 0.001 
Fiber intake (g/day) 30.3 28.8 26.9 24.5 < 0.001 
Alcohol intake (g/day) 7.0 6.5 6.8 7.3 0.073 
a P values were determined by the chi-square test or ANOVA for the difference between the groups. 
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Table 2. Hazard ratios (HRs) and 95 % CIs of CVD according to egg consumption. 
 Egg consumption 
 < 1/week 1week 2-4/week >4/week 
Incident cases of CVD 11 16 53 11 
Multivariable 1 1 (ref.) 0,77 (0,36-1,67) 0,99 (0,51-1,91) 1,10 (0,45-2,52) 
Multivariable 2 1 (ref.) 0,78 (0,36-1,69) 0,99 (0,51-1,95) 1,08 (0,45-2,59) 
Multivariable 3 1 (ref.) 0,78 (0,36-1,70) 1,00 (0,51-1,97) 1,10 (0,46-2,63) 
Multivariable 1: adjusted for age (continuous), sex and total energy intake (continuous) 
Multivariable 2: additionally adjusted for  adherence to the Mediterranean food pattern (3 categories) 
Multivariable 3: additionally adjusted for alcohol intake (4 categories), baseline BMI (Kg/m2, continuous), smoking status (3 
categories), physical activity during leisure time (MET-hours/week, continuous), family history of CVD years (yes/no), self-
reported diabetes (yes/no), self-reported hypertension (yes/no), self-reported hypercholesterolemia (yes/no). 
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